Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Pliant Therapeutics Inc (NASDAQ: PLRX) closed at $1.66 in the last session, up 3.75% from day before closing price of $1.60. In other words, the price has increased by $3.75 from its previous closing price. On the day, 1.3 million shares were traded.
Ratios:
We take a closer look at PLRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.03 and its Current Ratio is at 11.03. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Coulie Bernard sold 52,419 shares for $11.20 per share. The transaction valued at 587,150 led to the insider holds 430,517 shares of the business.
Cummings Keith Lamont sold 20,148 shares of PLRX for $225,680 on Jan 17 ’25. The Chief Financial Officer now owns 262,608 shares after completing the transaction at $11.20 per share. On Jan 17 ’25, another insider, Hull Hans, who serves as the Chief Business Officer of the company, sold 15,936 shares for $11.20 each. As a result, the insider received 178,501 and left with 211,558 shares of the company.
Stock Price History:
Over the past 52 weeks, PLRX has reached a high of $16.10, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 16.43%, while the 200-Day Moving Average is calculated to be -80.36%.
Shares Statistics:
A total of 61.39M shares are outstanding, with a floating share count of 54.10M. Insiders hold about 11.86% of the company’s shares, while institutions hold 87.43% stake in the company.
